Company Overview
B (B) is a publicly traded company listed on with a market capitalization of $68.77B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 18.8%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 16.7%.
Net profit has compounded at 126.1% per year over the last five years.
Revenue has grown at a 15.5% CAGR over the past five years.
Trades at an undemanding P/E of 14.0.
Maintains a net profit margin of 29.4%.
Recent Developments
- Dec 2025 Revenue of $16.96B (+31.2% YoY); net profit $4.99B.
- Trailing 12 Months Year-on-year growth — revenue +31.2%, earnings +132.9%.
- 5-Year Trend Long-term compounding — revenue CAGR 15.5%, profit CAGR 126.1%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 15.47% |
| 1 Year: | 31.22% |
Compounded Profit Growth
| 5 Years: | 126.10% |
| 1 Year: | 132.88% |
Stock Price Performance
| 1 Year: | +89.30% |
| 6 Months: | -12.54% |
| 3 Months: | +6.46% |
| 1 Month: | +11.37% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)65.02 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 29.4%.
- Compounding revenue at 15.5% over 5 years.
- Profit CAGR of 126.1% over 5 years.
- Generates positive free cash flow.
CONS
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 3.13B | 3.68B | 4.15B | 6.00B | 5.22B |
| Cost of Revenue | 1.78B | 1.88B | 1.89B | 2.71B | 2.10B |
| Gross Profit | 1.34B | 1.80B | 2.26B | 3.29B | 3.12B |
| Operating Expenses | 115.00M | 113.00M | 173.00M | 285.00M | 152.00M |
| Operating Income | 1.23B | 1.69B | 2.08B | 3.00B | 2.97B |
| EBITDA | 1.59B | 1.85B | 2.94B | 4.64B | 3.83B |
| Interest Expense | 117.00M | 58.00M | 99.00M | 37.00M | 100.00M |
| Pretax Income | 1.06B | 1.36B | 2.38B | 4.01B | 3.23B |
| Tax Provision | 278.00M | 102.00M | 477.00M | 794.00M | 747.00M |
| Net Income | 474.00M | 811.00M | 1.30B | 2.41B | 1.60B |
| Diluted EPS | 0.27 | 0.47 | 0.76 | - | 0.96 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 11.01B | 11.40B | 12.92B | 16.96B |
| Cost of Revenue | - | 7.50B | 7.93B | 7.96B | 8.27B |
| Gross Profit | - | 3.52B | 3.46B | 4.96B | 8.69B |
| Operating Expenses | - | 492.00M | 655.00M | 777.00M | 686.00M |
| Operating Income | - | 3.02B | 2.81B | 4.18B | 8.01B |
| EBITDA | - | 4.02B | 5.21B | 6.95B | 11.07B |
| Interest Expense | - | 341.00M | 350.00M | 423.00M | 358.00M |
| Pretax Income | - | 1.68B | 2.81B | 4.61B | 8.80B |
| Tax Provision | - | 664.00M | 861.00M | 1.52B | 1.65B |
| Net Income | - | 432.00M | 1.27B | 2.14B | 4.99B |
| Diluted EPS | - | 0.24 | 0.72 | 1.22 | 2.93 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 45.97B | 45.81B | 47.63B | 51.58B |
| Current Assets | - | 8.46B | 7.44B | 7.63B | 10.22B |
| Cash & Equivalents | - | 4.44B | 4.15B | 4.07B | 6.71B |
| Inventory | - | 1.78B | 1.78B | 1.94B | 2.07B |
| Receivables | - | 188.00M | 246.00M | 204.00M | 250.00M |
| Total Liabilities | - | 14.68B | 13.81B | 14.37B | 15.66B |
| Current Liabilities | - | 3.12B | 2.36B | 2.64B | 3.50B |
| Long Term Debt | - | 5.15B | 5.13B | 5.13B | 5.07B |
| Total Debt | - | 5.25B | 5.22B | 5.26B | 5.21B |
| Total Equity | - | 22.77B | 23.34B | 24.29B | 26.56B |
| Shares Outstanding | - | 1.76B | 1.76B | 1.73B | 1.68B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 3.48B | 3.73B | 4.49B | 7.69B |
| Investing Cash Flow | - | -1.71B | -2.82B | -2.76B | -1.24B |
| Financing Cash Flow | - | -2.60B | -1.21B | -1.79B | -3.82B |
| Capital Expenditure | - | -3.05B | -3.09B | -3.17B | -3.82B |
| Free Cash Flow | - | 432.00M | 646.00M | 1.32B | 3.87B |
| Net Change in Cash | - | -834.00M | -289.00M | -68.00M | 2.63B |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 31.9% | 30.4% | 38.4% | 51.3% |
| Operating Margin % | - | 27.5% | 24.7% | 32.4% | 47.2% |
| Net Margin % | - | 3.9% | 11.2% | 16.6% | 29.4% |
| ROE % | - | 1.9% | 5.4% | 8.8% | 18.8% |
| ROCE % | - | 7.1% | 6.5% | 9.3% | 16.6% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for B
Why Barrick Mining (B) Stock Is Up Today - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxNUWIwVkhuejJSNGNsbkhLa3M4VVQtdnBhbFY1dFh0MFJsU3JvX1F0V2hfNUpRcjM0dVl3VXNWcElyb0JSVVZrMWVFOVR0R0E3dzhSX2ZFY094aHRkUGdYOEstelF3QkV4STZtTDNHSDlSVHl0MnRzSzl2M0RjaGRFT3hISQ?oc=5" targe…
Novo Nordisk (CPSE:NOVO B) Stock Still Looks Like A Bargain As Shares Fell 48% - Yahoo! Finance Canada
<a href="https://news.google.com/rss/articles/CBMifkFVX3lxTE9CRnE1UE9ETHRXLVd5TlVVUWRDYkZYYzhreWZsZlR1S04tVnpMeXRNWG5YQUlHa1o5TFhDcTJXRl9yUUhvUnVYN2lRcElkbGdWVXpTYW1OMFEybmtZaF90SHNYclBBeWs4VVBtSU5NTTl0TDQ4alBybnJnLVoxdw?oc=5" target="_blan…
Novo Nordisk A/S Class B Stock 12‑Month Price Target Cut to DKK 318.86, Implies 4% Upside - TradingView
<a href="https://news.google.com/rss/articles/CBMi4wFBVV95cUxPSEFrNkVoUFp2X2wtcFQ0ajVsTHdNZ3pIZlJpdHdOVzFzZFBGczJUbDhSM2dzeEx0THZzSlRyS1lKQ0x0MHJEd1l2U2M5MmFYcFZfYjlMZ2dyd3RsSUtteVNfM0NvOFFpd2JuTU9BNWNPTGsxYU1Ld0tEckZPX3RoakVIXzlxUzFmQTBROW…
Celestica announces $3B common stock offering; shares drop (CLS:NYSE) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxOVWdxTkRYQ2h2QU5RcTduOE84QWhFMVF2bXBPelNhNzJNSDMyNk8wMmlZZFh3YmFrT2JyalpnS1IzcEZFWVdYRjUwZ3BUNENxVXNCbWR0SllaYlFyWHQycEJDVl83aW4yWW15VmYwMzBVdnIyMFZ0QV9DR19UdU9SWjlNVEY1dnRmRkZTbD…
Crawford (CRD.B) Stock Jumps As Margin Rebound Lifts Profit Outlook - simplywall.st
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxOV1NmWkplT3g1QmRZOXZyLWRLb0VxbTBCbUhxRHJtaXBvOUhSZnlteXR2bk1ZVjlOOGtCMHUzTnpUU29vMHhoSFNjdzFubTdLLXNzZzNwRENrZ0hwSGtPNFpxa0VpZVd4QUZGdTExbk8zZ2ZDWXVzOVlxcVZnYno5cGtfY1VHWTVablZFZn…
How the (CGX.DB.B) price action is used to our Advantage - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxNbVQzNklaYzhHN3ZDRF9Yd3pZQXRyMnE4ZFVndTRWV0JDN0pGQWVhdlZWOG9sZUY4bjhEYlZ6R01XLWRKUml6am10LU1tQ0dudnIzbGxmajZwSFlKaDJpYVdTTXZlU2tjQmhUeGpYQml2WTQzS1czM2RoMWJ2VUZwSmNsX3dtVGZpYktlbF…
B — Frequently Asked Questions
What is the current share price of B?
As of 2026-08-05 17:25 PDT, B trades at $41.05 on NASDAQ/NYSE. Its 52-week range is $21.68 to $52.32.
What is the market capitalisation of B?
B has a market capitalisation of $68.77B on NASDAQ/NYSE.
What is the P/E ratio of B?
B trades at a trailing price-to-earnings (P/E) ratio of 14.01. Its price-to-book (P/B) ratio is 2.59.
What is the return on equity (ROE) of B?
B has a return on equity (ROE) of 18.80%. Its return on capital employed (ROCE) is 16.65%.
Is B a good stock to buy?
This page provides a data-driven analysis of B, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.